The first scheduled trial of a wrongful death suit against Merck & Co. over its painkiller Vioxx was postponed Friday by an Alabama judge to avoid conflicts with federal litigation. 

Circuit Judge John Rochester said he decided to push back the trial – initially set for May 23 – after conferring with other judges who are presiding over Vioxx cases.

U.S. District Judge Eldon E. Fallon had asked that the case be postponed so it wouldn’t interfere with federal litigation. Fallon, who is based in New Orleans, is overseeing all the federal Vioxx cases at this stage.

Last week, Rochester rejected Merck’s motion that the Alabama state court suit be dismissed and put attorneys for both sides into private talks over a possible settlement. But no agreement was reached in the suit brought by Cheryl Rogers, an Alabama woman who blames her husband’s death on the company’s once-popular pain reliever.

Rogers’ attorney Jere Beasley said the delay would give his firm more time to investigate and establish more evidence against Merck. “Eventually, they’ll have to face us.”

Merck attorney Mike Brock, in a statement Friday, said delaying the state trial and focusing on federal litigation will “avoid duplication and inconsistencies in the judicial process.”

Rochester did not indicate in his order when a new trial date may be set.

Merck, based in Whitehouse Station, N.J., pulled Vioxx off the market last September after a study showed it doubled the risk of heart attacks and strokes in patients taking the drug for more than 18 months. So far, more than 2,400 lawsuits have been filed involving Vioxx.

Earlier this year, Fallon was selected to handle all pretrial proceedings such as gathering evidence and interviewing witnesses in the federal cases. The cases will be returned to their original jurisdictions after the pretrial proceedings.

There are 477 cases in the multi-district federal litigation and another 382 are being moved to Fallon’s court.

We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Vioxx settlement payments to begin in August

Merck & Co., manufacturer of Vioxx, announced it will make the first payment of $500 million on Aug....

Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.